Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

She explains that Pfizer (PFE), Eli Lilly (LLY), and Novo are among the candidates who could offer weight loss drugs in pill form rather than through injection, which could transform the market.

Unlike fad purchases, these particular items have merit. They’ve either been rigorously tested and approved in our labs or thoroughly vetted in our editors’ homes, where they’ve gone through ...

Remember to redeem these codes as soon as possible to enjoy your free items and avatar accessories. Keep an eye on this page for updates, as new codes can appear anytime. Alexander Dimitrov is a rare ...